Related Experiment Video
Updated: Jun 3, 2025
12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.7K
Enhanced antibody responses in CD19-Cre mice
Diogo M Cunha1,2,3, Sara Hernández-Pérez1,2,3,4, Pieta K Mattila5,6,7
1Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Turku, Finland.
Scientific Reports
|January 8, 2025
Summary
The CD19-Cre mouse model, used for B cell research, shows altered immune responses. These mice exhibit heightened antibody production and modified B cell activity, impacting their utility in immunological studies.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- The CD19-Cre mouse model is essential for B cell-specific genetic studies.
- This model involves heterozygosity for CD19, a key B cell receptor coreceptor, leading to reduced CD19 expression.
- The impact of diminished CD19 expression on B cell activation remains incompletely understood.
Purpose of the Study:
- To investigate the consequences of CD19 deficiency in CD19-Cre mice on B cell function and immune responses.
- To evaluate the utility of the CD19-Cre model in B cell research.
Main Methods:
- Immunization of CD19-Cre mice with T-dependent (NP-KLH) and T-independent (NP-Ficoll) antigens.
- Measurement of basal immunoglobulin M (IgM) levels.
- In vitro B cell stimulation assays (LPS, IFNγ) to assess proliferation and class-switch recombination.
- Analysis of B cell antigen receptor (BCR) signaling.
Main Results:
- CD19-Cre mice demonstrated significantly enhanced antibody responses to both T-dependent and T-independent immunizations.
- Elevated basal IgM levels were observed in CD19-Cre mice.
- In vitro studies showed enhanced B cell class-switch recombination but reduced proliferation upon stimulation, with no major changes in BCR signaling.
Conclusions:
- The CD19-Cre model exhibits altered B cell responses, including heightened antibody production and modified B cell activity.
- These findings suggest that the reduced CD19 expression in CD19-Cre mice significantly impacts B cell function.
- Researchers should carefully consider these immunological alterations when utilizing the CD19-Cre mouse model for B cell studies.
